All Stories

  1. Placental Growth Factor Led Management of the Small for Gestational Age Fetus: Randomised Controlled Feasibility Study
  2. Interventions to Improve Outcomes After Pregnancy Loss: A Systematic Review
  3. Acceptable Nomenclature for Pregnancy Loss Care: A Cross‐Sectional Observational Survey
  4. The Supporter Needs Supporting Too: A Qualitative Study to Understand the Maternity Care Experience for Partners Following a Previous Perinatal Death
  5. Service users’ experiences of maternity care in England informed by the Saving Babies’ Lives Care Bundle Version 2: A reflexive thematic analysis
  6. Cerebroplacental ratio-based management versus care as usual in non-small-for-gestational-age fetuses at term with maternal perceived reduced fetal movements (CEPRA): a multicentre, cluster-randomised controlled trial
  7. Evaluating the implementation of the Saving Babies Lives Care Bundle Version 2 from service user and healthcare professionals’ perspectives: a questionnaire study
  8. Evaluation of a co-designed digital animation in service improvement (DAISI) sharing messages around modifiable behaviours to reduce the risk of stillbirth
  9. Tommy’s National Rainbow Clinic Study: a protocol for a multi-site cohort study to evaluate a specialist antenatal service for women and families following a stillbirth or neonatal death
  10. Development of a prognostic model for pregnancy outcome in extremely early onset fetal growth restriction: A retrospective cohort study.
  11. A Core Outcome Set for Stillbirth Care: An International Consensus Study
  12. Acceptable nomenclature for pregnancy loss care in the UK: A cross-sectional observational survey
  13. Psychological Distress, Post‐Traumatic Stress and Emotional Suppression in a Pregnancy After a Perinatal Death: A Longitudinal Survey
  14. Determining the key elements of community-based care for women and partners following a stillbirth or second trimester miscarriage: protocol for a realist synthesis
  15. Understanding a Potential Role for the NLRP3 Inflammasome in Placenta‐Mediated Pregnancy Complications
  16. Impact of a dedicated antenatal specialist service for women with a history of stillbirth: the rainbow clinic
  17. Risk Factors for Adverse Pregnancy Outcomes in Reduced Fetal Movement: An IPD Meta‐Analysis
  18. A core outcome set for stillbirth care: an international consensus study
  19. Fathers’ experiences of perinatal death following miscarriage, stillbirth, and neonatal death: A meta-ethnography
  20. Parents’ psychological distress, post-traumatic stress, and emotional suppression in a pregnancy following a perinatal death: A questionnaire study
  21. The effect of the use of e-cigarettes during pregnancy on maternal, fetal and infant health outcomes: A scoping review protocol
  22. Identifying factors associated with adverse pregnancy outcomes in women with reduced fetal movements in the third trimester of pregnancy: An Individual Participant Data Meta-Analysis
  23. Virtual crossmatching reveals upregulation of placental HLA-Class II in chronic histiocytic intervillositis
  24. Strengthening open disclosure in maternity services in the English NHS: the DISCERN realist evaluation study
  25. Dynamic Prediction of Perinatal Outcome in Pregnancies After Stillbirth or Perinatal Death: A Pilot Study to Establish Proof-of-Concept and Explore Method Feasibility
  26. Measuring EQ-5D-5L utility values in parents who have experienced perinatal death
  27. Risk of stillbirth after a previous caesarean delivery: A Swedish nationwide cohort study
  28. The carbon footprint of different modes of birth in the UK and the Netherlands: An exploratory study using life cycle assessment
  29. Mothers working to prevent early stillbirth study (MiNESS 20–28): a case–control study protocol
  30. Decreased fetal movements: Report from the International Stillbirth Alliance conference workshop
  31. Subsequent pregnancy outcomes after second trimester miscarriage or termination for medical/fetal reason: A systematic review and meta‐analysis of observational studies
  32. Risk of stillbirth and adverse pregnancy outcomes in a third pregnancy when an earlier pregnancy has ended in stillbirth
  33. Assessment of the association between ambient air pollution and stillbirth in the UK: Results from a secondary analysis of the MiNESS case–control study
  34. Does fetal size affect maternal perception of fetal movements? Evidence from an individual participant data meta‐analysis
  35. The carbon footprint of different modes of birth in the UK and the Netherlands: an exploratory study using life cycle assessment
  36. Development of core outcome sets for studies relating to awareness and clinical management of reduced fetal movement
  37. Risk of stillbirth after a previous caesarean delivery: A Swedish nationwide cohort study
  38. Evaluating antenatal risk in twin pregnancies—A feasibility study to identify modifiable factors associated with adverse pregnancy outcomes
  39. Risk factors for late preterm and term stillbirth: A secondary analysis of an individual participant data meta‐analysis
  40. Information about fetal movements and stillbirth trends: Analysis of time series data
  41. Role of ethnicity in high-level obstetric clinical incidents: a review of cases from a large UK NHS maternity unit
  42. ‘Moving towards understanding’, acceptability of investigations following stillbirth in sub‐Saharan Africa: A grounded theory study
  43. Women’s experiences of a pregnancy whilst attending a specialist antenatal service for pregnancies after stillbirth or neonatal death: a qualitative interview study
  44. Morphological and functional changes in placentas from prolonged pregnancies
  45. Managing stillbirth: taking care to investigate the cause and provide care for bereaved families
  46. Development of dynamic image analysis methods to measure vascularisation and syncytial nuclear aggregates in human placenta
  47. Investigation of the critical factors required to improve the disclosure and discussion of harm with affected women and families: a study protocol for a qualitative, realist study in NHS maternity services (the DISCERN study)
  48. Research Priority Setting Partnership for placental pathology
  49. A Systematic Review of the Safety of Blocking the IL-1 System in Human Pregnancy
  50. Understanding pregnancy as a teachable moment for behaviour change: a comparison of the COM-B and teachable moments models
  51. Pandemic stress and SARS-CoV-2 infection are associated with pathological changes at the maternal-fetal interface
  52. Interventions to increase maternal awareness of fetal movements no more effective than standard care
  53. Factors influencing health behaviour change during pregnancy: a systematic review and meta-synthesis
  54. Stillbirth rates, service outcomes and costs of implementing NHS England’s Saving Babies’ Lives care bundle in maternity units in England: A cohort study
  55. Parents’ experiences of care offered after stillbirth: An international online survey of high and middle‐income countries
  56. Parents’ Active Role and ENgagement in The review of their Stillbirth/perinatal death 2 (PARENTS 2) study: a mixed-methods study of implementation
  57. Can information regarding the index stillbirth determine risk of adverse outcome in a subsequent pregnancy? Findings from a single‐center cohort study
  58. Universal late pregnancy ultrasound screening to predict adverse outcomes in nulliparous women: a systematic review and cost-effectiveness analysis
  59. Associations between consumption of coffee and caffeinated soft drinks and late stillbirth—Findings from the Midland and North of England stillbirth case-control study
  60. Care in pregnancies subsequent to stillbirth or perinatal death
  61. Chronic histiocytic intervillositis: A breakdown in immune tolerance comparable to allograft rejection?
  62. Associations between social and behavioural factors and the risk of late stillbirth – findings from the Midland and North of England Stillbirth case‐control study
  63. Universal third-trimester ultrasonic screening using fetal macrosomia in the prediction of adverse perinatal outcome: A systematic review and meta-analysis of diagnostic test accuracy
  64. Can risk prediction models help us individualise stillbirth prevention? A systematic review and critical appraisal of published risk models
  65. Prediction of stillbirth: an umbrella review of evaluation of prognostic variables
  66. Delayed delivery of the second twin in a dichorionic diamniotic twin pregnancy for 136 days
  67. Umbilical cord characteristics and their association with adverse pregnancy outcomes: A systematic review and meta-analysis
  68. Investigation of the outcome of pregnancies complicated by increased fetal movements and their relation to underlying causes – A prospective cohort study
  69. A missense mutation of ErbB2 produces a novel mouse model of stillbirth associated with a cardiac abnormality but lacking abnormalities of placental structure
  70. Increased placental macrophages and a pro‐inflammatory profile in placentas and maternal serum in infants with a decreased growth rate in the third trimester of pregnancy
  71. Assessment of the quality, content and perceived utility of local maternity guidelines in hospitals in England implementing the saving babies’ lives care bundle to reduce stillbirth
  72. Evaluating improvement interventions using routine data to support a learning health system: research design, data access, analysis and reporting
  73. Intra‐placental arterial Doppler: A marker of fetoplacental vascularity in late‐onset placental disease?
  74. Need to ensure that improvements in stillbirth rates are also achieved in high‐risk groups
  75. Evaluating the accuracy and precision of sonographic fetal weight estimation models in extremely early‐onset fetal growth restriction
  76. The effect of high glucose on lipid metabolism in the human placenta
  77. The kynurenine pathway; A new target for treating maternal features of preeclampsia?
  78. Research priorities and potential methodologies to inform care in subsequent pregnancies following stillbirth: a web-based survey of healthcare professionals, researchers and advocates
  79. ‘Real experiences which increase empathy’ – a preliminary exploration of the utility of an audio archive describing parents’ and clinicians’ experiences of stillbirth
  80. Comments: Influence of the prone position on a stretcher for pregnant women on maternal and fetal hemodynamic parameters and comfort in pregnancy
  81. PARENTS 2 Study: a qualitative study of the views of healthcare professionals and stakeholders on parental engagement in the perinatal mortality review—from ‘bottom of the pile’ to joint learning
  82. Reduced fetal movement intervention Trial-2 (ReMIT-2): protocol for a pilot randomised controlled trial of standard care informed by the result of a placental growth factor (PlGF) blood test versus standard care alone in women presenting with reduced f...
  83. A mixed-methods evaluation of continuous electronic fetal monitoring for an extended period
  84. Alterations in maternally perceived fetal movement and their association with late stillbirth: findings from the Midland and North of England stillbirth case–control study
  85. “They told me all mothers have worries”, stillborn mother's experiences of having a ‘gut instinct’ that something is wrong in pregnancy: Findings from an international case–control study
  86. The Collaborative IPD of Sleep and Stillbirth (Cribss): is maternal going-to-sleep position a risk factor for late stillbirth and does maternal sleep position interact with fetal vulnerability? An individual participant data meta-analysis study protocol
  87. Saving babies’ lives project impact and results evaluation (SPiRE): a mixed methodology study
  88. Care of pregnant women with decreased fetal movements: Update of a clinical practice guideline for Australia and New Zealand
  89. Understanding the associations and significance of fetal movements in overweight or obese pregnant women: a systematic review
  90. Women's experiences of continuous fetal monitoring - a mixed-methods systematic review
  91. Stillbirth is associated with perceived alterations in fetal activity – findings from an international case control study
  92. Can promoting awareness of fetal movements and focusing interventions reduce fetal mortality? A stepped-wedge cluster randomised trial (AFFIRM)
  93. Assessing the quality of bereavement care after perinatal death: development and piloting of a questionnaire to assess parents’ experiences
  94. Use of biochemical tests of placental function for improving pregnancy outcome
  95. Professionals' views of fetal-monitoring support the development of devices to provide objective longer-term assessment of fetal wellbeing
  96. Placental Features of Late-Onset Adverse Pregnancy Outcome
  97. Protecting families from recurrent stillbirth
  98. Antiphospholipid Antibodies Alter Cell-Death-Regulating Lipid Metabolites in First and Third Trimester Human Placentae
  99. IFPA meeting 2014 workshop report: Animal models to study pregnancy pathologies; new approaches to study human placental exposure to xenobiotics; biomarkers of pregnancy pathologies; placental genetics and epigenetics; the placenta and stillbirth and f...
  100. IFPA Gábor Than Award Lecture: Recognition of placental failure is key to saving babies' lives
  101. Evaluation of the quality of guidelines for the management of reduced fetal movements in UK maternity units
  102. Continuous objective recording of fetal heart rate and fetal movements could reliably identify fetal compromise, which could reduce stillbirth rates by facilitating timely management
  103. Systematic review of placental pathology reported in association with stillbirth
  104. Circulating Cytokines and Alarmins Associated with Placental Inflammation in High-Risk Pregnancies
  105. A stochastic model for early placental development
  106. The Midland and North of England Stillbirth Study (MiNESS)
  107. UNDERSTANDING THE PLACENTAL AETIOLOGY OF FETAL GROWTH RESTRICTION; COULD THIS LEAD TO PERSONALIZED MANAGEMENT STRATEGIES?
  108. Parents’ experiences and expectations of care in pregnancy after stillbirth or neonatal death: a metasynthesis
  109. Preeclampsia Is Associated with Alterations in the p53-Pathway in Villous Trophoblast
  110. Analysis of syncytial nuclear aggregates in preeclampsia shows increased sectioning artefacts and decreased inter-villous bridges compared to healthy placentas
  111. A structured review and exploration of the healthcare costs associated with stillbirth and a subsequent pregnancy in England and Wales
  112. MANAGEMENT OF REDUCED FETAL MOVEMENTS
  113. Duration and method of tissue storage alters placental morphology – Implications for clinical and research practice
  114. Investigating the association of villitis of unknown etiology with stillbirth and fetal growth restriction – A systematic review
  115. Peripartum and intrapartum assessment of the fetus
  116. Syncytial nuclear aggregates in normal placenta show increased nuclear condensation, but apoptosis and cytoskeletal redistribution are uncommon
  117. A randomised controlled trial comparing standard or intensive management of reduced fetal movements after 36 weeks gestation-a feasibility study
  118. Interventions for supporting parents’ decisions about autopsy after stillbirth
  119. Bereaved parents’ experience of stillbirth in UK hospitals: a qualitative interview study
  120. Sharing experiences to improve bereavement support and clinical care after stillbirth: report of the 7th annual meeting of the international stillbirth alliance
  121. Identification of autophagic vacuoles and regulators of autophagy in villous trophoblast from normal term pregnancies and in fetal growth restriction
  122. A high-throughput colorimetric-assay for monitoring glucose consumption by cultured trophoblast cells and placental tissue
  123. Correlation between abnormal placental appearance at routine 2nd trimester ultrasound scan and histological examination of the placenta after birth
  124. Abnormalities of the placenta
  125. Reduced fetal movements
  126. Predictors of Poor Perinatal Outcome following Maternal Perception of Reduced Fetal Movements – A Prospective Cohort Study
  127. Placental expression of anti-angiogenic proteins in mirror syndrome: A case report
  128. A difficult conversation? The views and experiences of parents and professionals on the consent process for perinatal postmortem after stillbirth
  129. Post-mortem examination after stillbirth: views of UK-based practitioners
  130. A Metabolomic Approach Identifies Differences in Maternal Serum in Third Trimester Pregnancies That End in Poor Perinatal Outcome
  131. Maternal Perception of Reduced Fetal Movements Is Associated with Altered Placental Structure and Function
  132. Maternal perception of altered fetal activity and the risk of late stillbirth
  133. IFPA Meeting 2011 workshop report I: Placenta: Predicting future health; roles of lipids in the growth and development of feto-placental unit; placental nutrient sensing; placental research to solve clinical problems – A translational approach
  134. IFPA Meeting 2011 workshop report III: Placental immunology; epigenetic and microRNA-dependent gene regulation; comparative placentation; trophoblast differentiation; stem cells
  135. Do medical certificates of stillbirth provide accurate and useful information regarding the cause of death?
  136. Erratum to “Abstracts for the IFPA Meeting 2011” [Placenta 32 (2011) A1–A149]
  137. A case of confined placental mosaicism with double trisomy associated with stillbirth
  138. The metabolome of human placental tissue: investigation of first trimester tissue and changes related to preeclampsia in late pregnancy
  139. Fetal blood sampling in early labour: is there an increased risk of operative delivery and fetal morbidity?
  140. Review: The effects of oxygen on normal and pre-eclamptic placental tissue – insights from metabolomics
  141. Bladder perforation: A rare complication during diagnostic hysteroscopy
  142. Identifying placental dysfunction in women with reduced fetal movements can be used to predict patients at increased risk of pregnancy complications
  143. Intra-uterine growth restriction is associated with increased apoptosis and altered expression of proteins in the p53 pathway in villous trophoblast
  144. Towards an end to stillbirths
  145. Changes in the Metabolic Footprint of Placental Explant-Conditioned Medium Cultured in Different Oxygen Tensions from Placentas of Small for Gestational Age and Normal Pregnancies
  146. Placental Apoptosis in Health and Disease
  147. Auscultation of the fetal heart in early pregnancy
  148. Concurrent maternal and fetal ovarian cysts
  149. The use of the birthing pool after a diagnosis of stillbirth
  150. Changes in the Metabolic Footprint of Placental Explant-Conditioned Culture Medium Identifies Metabolic Disturbances Related to Hypoxia and Pre-Eclampsia
  151. Detection and management of decreased fetal movements in Australia and New Zealand: A survey of obstetric practice
  152. A Case of Intrauterine Growth Restriction in Association with Placental Mesenchymal Dysplasia with Abnormal Placental Lymphatic Development
  153. Can post-mortem examination of the placenta help determine the cause of stillbirth?
  154. Elevated bile acids associated with acute hepatitis A infection in the third trimester of pregnancy
  155. Predicting poor perinatal outcome in women who present with decreased fetal movements
  156. Altered Expression of Regulators of Caspase Activity within Trophoblast of Normal Pregnancies and Pregnancies Complicated by Preeclampsia
  157. Live and Let Die – Regulation of Villous Trophoblast Apoptosis in Normal and Abnormal Pregnancies
  158. Analysis of the Metabolic Footprint and Tissue Metabolome of Placental Villous Explants Cultured at Different Oxygen Tensions Reveals Novel Redox Biomarkers
  159. Fetal Movement Assessment
  160. Management of Decreased Fetal Movements
  161. Midwives’ and Obstetricians’ Knowledge and Management of Women Presenting With Decreased Fetal Movements
  162. Effects of Oxygen on Cell Turnover and Expression of Regulators of Apoptosis in Human Placental Trophoblast☆
  163. Methods of fetal movement counting and the detection of fetal compromise
  164. Erratum to “Formation of Syncytial Knots is Increased by Hyperoxia, Hypoxia and Reactive Oxygen Species” [Placenta 28, Supplement A, Trophoblast Research, Volume 21 (2007) S33–S40]
  165. Epidermal growth factor rescues trophoblast apoptosis induced by reactive oxygen species
  166. The Mitotic Manipulation of Cytotrophoblast Differentiation In Vitro
  167. Formation of Syncytial Knots is Increased by Hyperoxia, Hypoxia and Reactive Oxygen Species
  168. Oxidative Stress and Pregnancy Outcome: A Workshop Report
  169. OBSTETRIC MANAGEMENT OF TEENAGE PREGNANCY
  170. Placental cell turnover in health and disease
  171. Acupressure for the in-patient treatment of nausea and vomiting in early pregnancy: A randomized control trial
  172. A case of isolated peripartum elevation of alkaline phosphatase in pregnancy complicated by gestational diabetes
  173. Is regional anaesthesia better than general anaesthesia for caesarean section?
  174. A case of gestational diabetes arising following treatment with glucocorticosteroids for pemphigoid gestationis
  175. The use of levomepromazine in Hyperemesis Gravidarum resistant to drug therapy—A case series
  176. An evaluation of the use of an intra-operative uterine tourniquet during multiple myomectomy: Does this reduce blood loss and the need for blood transfusion?
  177. What investigation is appropriate following maternal perception of reduced fetal movements?
  178. The teaching and use of a mnemonic to improve the management of shoulder dystocia
  179. An unusual cause of urinary retention in early pregnancy
  180. A case of fetal pericardial effusion in association with maternal hypertension and HIV infection
  181. A retrospective study to determine if umbilical cord pH correlates with duration of delay between delivery of the head and body in shoulder dystocia
  182. The treatment of severe hypertension in pregnancy: a review of current practice and knowledge in West-Midlands maternity units
  183. Vasculitic lesion involving the uterine cervix in a patient with anti-nuclear antibodies